Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intra-arterial Chemotherapy for Retinoblastoma (IAC)

NCT04342572 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04342572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04342572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intra-arterial Chemotherapy for Retinoblastoma (IAC)
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
August 11, 2020
Completion date
March 21, 2025
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retinoblastoma